Skip to content
10-Q

Quarterly Report

Celator Pharmaceuticals Inc

0001144204-15-028364

← back to feed
Filed
May 7, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 7, 2015 33.74M sh
Long Term Debt Q1 2015 · Mar 31, 2015 $13.44M
Long Term Debt Q1 2015 · Dec 31, 2014 $9.84M
Short Term Debt Q1 2015 · Mar 31, 2015 $1.73M
Short Term Debt Q1 2015 · Dec 31, 2014 $284.96K
Stockholders Equity Q1 2015 · Mar 31, 2015 $17.8M
Stockholders Equity Q1 2015 · Dec 31, 2014 $21.91M
Current Liabilities Q1 2015 · Mar 31, 2015 $4.22M
Current Liabilities Q1 2015 · Dec 31, 2014 $3.29M
Total Liabilities Q1 2015 · Mar 31, 2015 $17.7M
Total Liabilities Q1 2015 · Dec 31, 2014 $13.21M
Current Assets Q1 2015 · Mar 31, 2015 $33.96M
Current Assets Q1 2015 · Dec 31, 2014 $33.57M
Total Assets Q1 2015 · Mar 31, 2015 $35.5M
Total Assets Q1 2015 · Dec 31, 2014 $35.12M
Capex Q1 2015 · Mar 31, 2014 $2.44K
Cash And Equivalents Q1 2015 · Mar 31, 2014 $20.81M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $23.59M
Sga Expense Q1 2015 · Mar 31, 2014 $1.89M
Rd Expense Q1 2015 · Mar 31, 2014 $2.97M
Net Income Q1 2015 · Mar 31, 2014 −$4.28M
Operating Income Q1 2015 · Mar 31, 2014 −$4.27M